Foxp3 and CTLA-4 mRNA expression are higher in Tregs from the peripheral blood of patients with progressed and advanced pancreatic cancer, and there should further be a positive correlation between the IL-10 or TGFβ levels and the progression of pancreatic cancer [52]. This evidence concerns the gene TGFB1 and pancreatic neoplasm.